Ingevity/$NGVT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Ticker
$NGVT
Sector
Primary listing
NYSE
Employees
1,600
Headquarters
Website
Ingevity Metrics
BasicAdvanced
$1.8B
-
-$1.82
1.40
-
Price and volume
Market cap
$1.8B
Beta
1.4
52-week high
$60.77
52-week low
$28.49
Average daily volume
220K
Financial strength
Current ratio
1.269
Quick ratio
0.611
Long term debt to equity
838.885
Total debt to equity
912.744
Interest coverage (TTM)
3.09%
Profitability
EBITDA (TTM)
365.7
Gross margin (TTM)
33.99%
Net profit margin (TTM)
-4.77%
Operating margin (TTM)
18.96%
Effective tax rate (TTM)
11.50%
Revenue per employee (TTM)
$860,000
Management effectiveness
Return on assets (TTM)
8.10%
Return on equity (TTM)
-204.65%
Valuation
Price to revenue (TTM)
1.275
Price to book
12.72
Price to tangible book (TTM)
-13.13
Price to free cash flow (TTM)
7.353
Free cash flow yield (TTM)
13.60%
Free cash flow per share (TTM)
6.583
Growth
Revenue change (TTM)
-6.57%
Earnings per share change (TTM)
-88.26%
3-year revenue growth (CAGR)
-5.17%
10-year revenue growth (CAGR)
3.30%
3-year earnings per share growth (CAGR)
-31.94%
10-year earnings per share growth (CAGR)
-2.54%
What the Analysts think about Ingevity
Analyst ratings (Buy, Hold, Sell) for Ingevity stock.
Ingevity Financial Performance
Revenues and expenses
Ingevity Earnings Performance
Company profitability
Ingevity News
AllArticlesVideos
Ingevity announces virtual strategic portfolio update for investors on December 8
Business Wire2 days ago
Ingevity announces dates for third quarter 2025 earnings release and webcast
Business Wire2 weeks ago
Ingevity names Ruth Castillo as senior vice president and president of Performance Materials
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ingevity stock?
Ingevity (NGVT) has a market cap of $1.8B as of November 08, 2025.
What is the P/E ratio for Ingevity stock?
The price to earnings (P/E) ratio for Ingevity (NGVT) stock is 0 as of November 08, 2025.
Does Ingevity stock pay dividends?
No, Ingevity (NGVT) stock does not pay dividends to its shareholders as of November 08, 2025.
When is the next Ingevity dividend payment date?
Ingevity (NGVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ingevity?
Ingevity (NGVT) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.